NCT06834334Completed
Clinical Effectiveness of Advanced Hybrid Closed-loop Systems for Achieving Time in Tight Range Among T1D Patients
Clinical Effectiveness of Advanced Hybrid Closed-loop Systems (AHCL) for Achieving Time in Tight Range (TiTR) of Interstitial Glucose Among Adult Type 1 Diabetes (T1D) Patients
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications. Therefore, the key to prevent and/or reduce the development of these chronic complications lies in an adequate and strict glycemic control. This study consist of a cross-sectional observational study among adult patients with type 1 diabetes (T1D). The main objective is to analyze the effect on time in tight range (TiTR, 70-140 mg/dL) of interstitial glucose between three different advanced hybrid closed-loop (AHCL) systems.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 189 (actual)
- First submitted
- 7 Feb 2025
- Start date
- 27 Feb 2025
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- Castilla-La Mancha Health Service
- Diseases
- Type 1 diabetes
- NCT number
- NCT06834334
What you commit to
- Study type: Observational
- Participants enrolled: 189
- From 27 Feb 2025 to the primary completion date, 1 Oct 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving treatment with insulin regimens other than AHCL.
- Having received AHCL treatment for less than 3 months in a row prior to inclusion in the study with the same system.
- No data on use of the AHCL system during the previous 14 days.
Other illness
- Other types of diabetes.
- Severe or uncontrolled psychiatric disorder.
Other
- Pregnancy or end of pregnancy less than 3 months ago or preparation for pregnancy.
Who the study is looking for
- Patients with type 1 diabetes.
- Age greater than or equal to 18 years.
- Treated with advanced hybrid closed-loop systems (AHCL) for at least 3 months
- Actived continuous glucose monitoring data in the last 14 days.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Badajoz University Hospital Coordinator of this site? Confirm its status | Badajoz | Spain | Unknown status |
| Ciudad Real General University Hospital Coordinator of this site? Confirm its status | Ciudad Real | Spain | Unknown status |
| Hospital Universitario Mutua de Tarrasa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.